Predictive Oncology Inc. (NASDAQ: POAI) Taps Its Chairman to be CEO
Current POAI Chairman J. Melville (“Mel”) Engle has been appointed to CEO positionEngle has held executive positions throughout his career at leading pharma and medical device companies, including Dey L.P. (a subsidiary of Merck KGaA), Allergan, Anika Therapeutics and ThermogenesisDuring his time at Merck’s Dey L.P., Engle transitioned the company from generics to branded products and grew sales from $250 million to $600 million The…